On 4 December 2025, Dr. Béla Merkely, rector of Semmelweis University and director of the Városmajor Heart and Vascular Center, was conferred an honorary doctorate by Charles University in Prague. The ceremony, held in the historic Karolinum building, highlighted Dr. Merkely’s pioneering work in cardiovascular research and his role in fostering international collaboration between Hungarian and Czech institutions.
Founded in 1347, Charles University is one of the oldest universities in Europe. Its tradition of academic excellence and its extensive network of alumni—including Nobel laureates and leading scientists—make an honorary doctorate from this institution a highly respected accolade. For a Hungarian medical school, the award underscores the growing influence of Semmelweis University on the global stage.
Dr. Merkely’s career spans over 25 years of research, teaching, and clinical leadership. He has authored more than a thousand peer‑reviewed papers, amassed an h‑index of 88, and secured 104,000 independent citations. His research portfolio covers heart failure, rhythm disturbances, acute coronary syndromes, cardiac remodeling in athletes, and the role of endogenous vasoactive factors. Under his guidance, the Városmajor Heart and Vascular Center became one of Europe’s largest integrated cardiac facilities.
One of the hallmarks of Dr. Merkely’s career is his commitment to cross‑border research. His partnership with Czech cardiologist Dr. Petr Widimský, dean of the Third Faculty of Medicine at Charles University, exemplifies how sustained collaboration can lead to landmark studies and shared recognition.
The BUDAPEST trial, initiated in 2018, investigated the benefits of adding a left epicardial electrode to patients with heart failure who already had a pacemaker. The multicenter study demonstrated significant improvements in cardiac function and patient outcomes, influencing guidelines worldwide. Dr. Merkely’s team is now working on the second phase, focusing on patients with left bundle branch block after transcatheter aortic valve implantation.
While honorary doctorates are rare, understanding the criteria and pathways can help researchers position themselves for such honors.
Universities typically consider:
Semmelweis University offers a range of facilities and programs that support cardiovascular research and academic growth.
The university’s state‑of‑the‑art laboratories, imaging suites, and biobank enable cutting‑edge studies. Researchers can access:
To learn more about available funding, visit Semmelweis University’s research portal.
Semmelweis University’s alumni network spans over 30,000 former students worldwide. Engaging with alumni can open doors to joint projects, mentorship, and career opportunities.
Join the alumni community at Semmelweis Alumni and explore collaborative possibilities.
Cardiovascular science is rapidly evolving. Emerging technologies and interdisciplinary approaches promise to reshape patient care.
Researchers should:
Dr. Béla Merkely’s honorary doctorate from Charles University exemplifies the impact of sustained research excellence, international collaboration, and leadership in cardiovascular medicine. For researchers and clinicians in Hungary and beyond, his career offers a roadmap to academic recognition and patient‑centered innovation.
Ready to advance your cardiovascular research? Explore Semmelweis University’s cardiovascular research programs and discover how you can contribute to the next generation of breakthroughs.
Have questions about collaborating with Semmelweis University? Contact our international collaborations office today.
Join our alumni network to stay connected with leading experts and share your own research milestones. Connect with Semmelweis Alumni now.
For more insights on the BUDAPEST trial and its implications, read our latest news releases.